作者: Peter J. Dunn
DOI: 10.1021/OP040019C
关键词: Phosphodiesterase 、 Sildenafil 、 Tadalafil 、 Vardenafil 、 Pharmacology 、 Phosphodiesterase V Inhibitors 、 Medicine
摘要: The literature syntheses (including patents) of three commercial phosphodiesterase(V) (PDE5) inhibitors (sildenafil, vardenafil, and tadalafil) are reviewed with particular emphasis on large-scale manufacture. For each these compounds, some impressive chemical development work has been reported.